Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

作者
Marion Zillhardt,Sun-Mi Park,Iris L. Romero,Kenjiro Sawada,ANTHONY G. MONTAG,Thomas N Krausz,S. Diane Yamada,Marcus E. Peter,Ernst R. Lengyel
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:17 (12): 4042-4051 被引量:117
标识
DOI:10.1158/1078-0432.ccr-10-3387
摘要

PURPOSE: Currently, there are no approved targeted therapies for the treatment of ovarian cancer, despite the fact that it is the most lethal gynecological malignancy. One proposed target is c-Met, which has been shown to be an important prognostic indicator in a number of malignancies, including ovarian cancer. The objective of this study was to determine whether an orally available multikinase inhibitor of c-Met and vascular endothelial growth factor receptor-2 (foretinib, GSK1363089) blocks ovarian cancer growth. EXPERIMENTAL DESIGN: The effect of foretinib was tested in a genetic mouse model of endometrioid ovarian cancer, several ovarian cancer cell lines, and an organotypic 3D model of the human omentum. RESULTS: In the genetic mouse model, treatment with foretinib prevented the progression of primary tumors to invasive adenocarcinoma. Invasion through the basement membrane was completely blocked in treated mice, whereas in control mice, invasive tumors entirely replaced the normal ovary. In 2 xenograft mouse models using human ovarian cancer cell lines, the inhibitor reduced overall tumor burden (86% inhibition, P < 0.0001) and metastasis (67% inhibition, P < 0.0001). The mechanism of inhibition by foretinib involved (a) inhibition of c-Met activation and downstream signaling, (b) reduction of ovarian cancer cell adhesion, (c) a block in migration and invasion, (d) reduced proliferation mediated by a G(2)-M cell-cycle arrest, and (e) induction of anoikis. CONCLUSIONS: This study shows that foretinib blocks tumorigenesis and reduces invasive tumor growth in different models of ovarian cancer by affecting several critical tumor functions. We believe that it provides a rationale for the further clinical development of foretinib for the treatment of ovarian cancer.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kdqiu发布了新的文献求助30
1秒前
史迪仔发布了新的文献求助10
1秒前
FU发布了新的文献求助10
1秒前
2秒前
Jenifer完成签到,获得积分10
2秒前
DS发布了新的文献求助10
2秒前
司空蓝发布了新的文献求助10
3秒前
3秒前
xxxx完成签到 ,获得积分10
3秒前
优美的玉米完成签到,获得积分10
4秒前
Eli完成签到,获得积分10
4秒前
4秒前
五味子完成签到,获得积分10
4秒前
5秒前
完美世界的应助被yuer采纳,获得10
5秒前
Lucas的应助被葛稀采纳,获得10
6秒前
6秒前
歪歪发布了新的文献求助10
6秒前
五味子发布了新的文献求助10
7秒前
我是老大的应助被阿飞大师采纳,获得10
7秒前
00完成签到,获得积分10
7秒前
Afesoa完成签到,获得积分10
7秒前
8秒前
山山而川发布了新的文献求助10
8秒前
NIKO完成签到,获得积分10
8秒前
zzz完成签到,获得积分10
8秒前
jiangyujiangnan完成签到 ,获得积分10
10秒前
10秒前
思你如初完成签到 ,获得积分10
10秒前
CodeCraft的应助被冷傲夜梅采纳,获得10
10秒前
Lucas的应助被samo采纳,获得10
10秒前
可爱的函函的应助被筱12采纳,获得10
10秒前
11秒前
11秒前
xyz完成签到,获得积分20
12秒前
Hello的应助被木子采纳,获得10
12秒前
骑猪的飞行员完成签到,获得积分10
12秒前
12秒前
G.Huang发布了新的文献求助30
13秒前
稳重的依风完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943